You have heard these calls before: a payer's provider reviews a denial for a procedure your specialist ordered after years of treating the patient. The reviewer asks questions that reveal little familiarity with the diagnosis. The denial stands, and your team logs it and moves on. That call may have violated state law, yet most revenue cycle leaders are not using that leverage effectively.
What the AMA Survey Confirmed
The 2025 AMA Prior Authorization Physician Survey, conducted in December 2025 among 1,000 practicing physicians, found that only 24% said medical-necessity denials are consistently reviewed by appropriately qualified clinicians. Among physicians who have participated in peer-to-peer reviews, only 16% said the health plan representative often or always had the appropriate qualifications. Those numbers point to a compliance gap in states with specialty-matching requirements. In those states, an adverse determination issued without the required clinical match may not satisfy the law.
The States Where the Law Has Teeth
More than half of U.S. states have utilization-review laws that address reviewer qualifications. Texas Insurance Code Section 4201.206 requires a payer, before issuing an adverse determination, to provide a discussion with a Texas-licensed physician of the same or similar specialty as the ordering physician. Texas regulators also require utilization review agents to maintain documentation supporting reviewer qualifications.
Other states have moved in the same direction. New Jersey's Ensuring Transparency in Prior Authorization Act, effective January 2025, requires the reviewing physician to share the treating physician's specialty or to have equivalent board certification or five years of experience treating the condition. Illinois requires a clinical peer in the same profession and the same or similar specialty. Connecticut tightened its standard effective January 2026. Oklahoma and Massachusetts also impose specialty-based peer-review requirements, though scope and enforcement vary.
The Enforcement Record
In October 2025, California's DMHC fined Cigna HealthCare of California $500,000 for denying claims without physicians conducting clinical reviews before the denials were issued and for using a review process that differed from its filed policy. In a 2025 consent order involving Oscar Insurance Company, Texas regulators found that 42% of a 50-case sample of initial adverse determinations did not include the required offer of peer-to-peer review before the denial was issued. Oscar paid a $225,000 penalty.
Three Steps That Belong in the Standard Workflow
First, ask the reviewing physician to identify their specialty credentials at the start of the peer-to-peer call. If the payer refuses to answer, or if the reviewer's specialty appears unrelated to the diagnosis or procedure at issue, document that immediately. In some states, including Texas, the payer must maintain documentation showing that the reviewer met the statutory qualification standard. A missing or unclear answer may be relevant evidence.
Second, document the peer-to-peer in both clinical and procedural terms. Record the reviewer's name, stated specialty, the date and time of the call, and whether the questions reflected familiarity with the relevant specialty-specific criteria. If the conversation suggests the reviewer did not understand the diagnosis, treatment protocol, or documentation standards at issue, note that in the appeal file alongside the medical arguments.
Third, when reviewer qualifications are in doubt, cite the applicable statute or regulatory standard in the appeal letter. Do not rely only on medical-necessity arguments if the denial process itself may have failed to satisfy state law. In states with explicit same-specialty or same-or-similar specialty requirements, naming the statutory section and describing the mismatch can change how the appeal is routed internally.
Filing the State Complaint
When a denial appears to violate a state reviewer-qualification requirement, filing a complaint with the state insurance regulator may be appropriate alongside the payer's internal appeal. Timing and process vary by state. Some regulators will accept a complaint while the internal appeal is still pending; others require the payer's provider-dispute process to run first. Either way, the complaint is stronger when it includes the denial, the peer-to-peer documentation, the reviewer-qualification issue, the relevant statutory or regulatory standard, and a factual explanation of how the review fell short. None of this requires outside counsel in an ordinary case.
The ERISA Caveat
This framework applies primarily to fully insured commercial plans subject to state insurance regulation. Self-funded employer plans governed by ERISA are largely exempt from these state utilization-review requirements. In practice, that means many commercially insured patients may have no enforceable protection under the statutes discussed here. That coverage gap, and what providers can do about it contractually, is the subject of the next article in this series.